BBA - Reviews on Cancer, ISSN 0304-419X, 12/2019, Volume 1872, Issue 2, p. 188310
Systemic therapy often results in the reduction of tumor size but rarely succeeds in eradicating all cancer cells. Drug efflux, persistence of cancer stem...
Tumor heterogeneity | Mutation | Drug resistance | Cancer
Tumor heterogeneity | Mutation | Drug resistance | Cancer
Journal Article
Current pharmaceutical design, 2017, Volume 23, Issue 32, pp. 4794 - 4806
There are over a dozen of approved cancer drugs, whose administration is tailored to predictive laboratory tests. The examples include estrogen and...
cancer therapy | cytotoxic therapy | mutation | targeted therapy | Predictive markers | expression | Genome-Wide Association Study | Humans | Neoplastic Cells, Circulating - metabolism | Tumor Burden | Molecular Targeted Therapy | Genetic Testing - methods | Neoplasms - drug therapy | Animals | Neoplasms - genetics | DNA Repair | Drug Design | Antineoplastic Agents - pharmacology | High-Throughput Nucleotide Sequencing | Neoplasms - pathology
cancer therapy | cytotoxic therapy | mutation | targeted therapy | Predictive markers | expression | Genome-Wide Association Study | Humans | Neoplastic Cells, Circulating - metabolism | Tumor Burden | Molecular Targeted Therapy | Genetic Testing - methods | Neoplasms - drug therapy | Animals | Neoplasms - genetics | DNA Repair | Drug Design | Antineoplastic Agents - pharmacology | High-Throughput Nucleotide Sequencing | Neoplasms - pathology
Journal Article
Frontiers in Molecular Biosciences, ISSN 2296-889X, 08/2018, Volume 5, p. 76
There are multiple applications of molecular tests in clinical oncology. Mutation analysis is now routinely utilized for the diagnosis of hereditary cancer...
Liquid biopsy | Molecular diagnostics | Predictive markers | Review | Carcinoma of unknown primary site | Hereditary cancer syndromes | TARGETED THERAPY | molecular diagnostics | ESTROGEN-RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | OVARIAN-CANCER | carcinoma of unknown primary site | CELL LUNG-CANCER | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | hereditary cancer syndromes | predictive markers | review | UNKNOWN PRIMARY SITE | COLORECTAL-CANCER | OF-AMERICAN-PATHOLOGISTS | CANCER SUSCEPTIBILITY GENE | liquid biopsy | Usage | Gene mutations | Molecular diagnostic techniques | Genetic aspects | Diagnosis | Research | Gene expression | Cancer
Liquid biopsy | Molecular diagnostics | Predictive markers | Review | Carcinoma of unknown primary site | Hereditary cancer syndromes | TARGETED THERAPY | molecular diagnostics | ESTROGEN-RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | OVARIAN-CANCER | carcinoma of unknown primary site | CELL LUNG-CANCER | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | hereditary cancer syndromes | predictive markers | review | UNKNOWN PRIMARY SITE | COLORECTAL-CANCER | OF-AMERICAN-PATHOLOGISTS | CANCER SUSCEPTIBILITY GENE | liquid biopsy | Usage | Gene mutations | Molecular diagnostic techniques | Genetic aspects | Diagnosis | Research | Gene expression | Cancer
Journal Article
Human Genetics, ISSN 0340-6717, 4/2009, Volume 125, Issue 3, pp. 239 - 246
Programmed cell death has been implicated in various aspects of cancer development. Apoptotic capacity is a subject of significant interindividual variations,...
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases | BREAST-CANCER | LUNG-CANCER | CHRONIC-LYMPHOCYTIC-LEUKEMIA | SYSTEMIC-LUPUS-ERYTHEMATOSUS | FUNCTIONAL POLYMORPHISM | GENETICS & HEREDITY | PROMOTER REGION | NECROSIS-FACTOR-ALPHA | SINGLE NUCLEOTIDE POLYMORPHISM | BLOOD MONONUCLEAR-CELLS | RADIATION-INDUCED APOPTOSIS | Genes, p53 | Neoplasms - etiology | Neoplasms - genetics | Humans | Risk Factors | Apoptosis - genetics | Genotype | Polymorphism, Single Nucleotide | DNA Damage | Neoplasms - pathology | Case-Control Studies | Polymorphism, Genetic
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases | BREAST-CANCER | LUNG-CANCER | CHRONIC-LYMPHOCYTIC-LEUKEMIA | SYSTEMIC-LUPUS-ERYTHEMATOSUS | FUNCTIONAL POLYMORPHISM | GENETICS & HEREDITY | PROMOTER REGION | NECROSIS-FACTOR-ALPHA | SINGLE NUCLEOTIDE POLYMORPHISM | BLOOD MONONUCLEAR-CELLS | RADIATION-INDUCED APOPTOSIS | Genes, p53 | Neoplasms - etiology | Neoplasms - genetics | Humans | Risk Factors | Apoptosis - genetics | Genotype | Polymorphism, Single Nucleotide | DNA Damage | Neoplasms - pathology | Case-Control Studies | Polymorphism, Genetic
Journal Article
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a...
CONSORTIUM | COMMON VARIANTS | POPULATION | INVESTIGATORS | MODIFIERS | SUBTYPES | SUSCEPTIBILITY ALLELES | GENETICS & HEREDITY | GENETIC-VARIANTS | SELECTION | ZNF365 | Genetic Predisposition to Disease | Genome-Wide Association Study | Prognosis | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Gene mutations | Genomics | Physiological aspects | Breast cancer | Genetic aspects | Research | Risk factors | Ovarian cancer | Cancer | Càncer d'ovari | Càncer de mama | Malalties hereditàries | Genètica humana | Genetic diseases | Human genetics | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medical research
CONSORTIUM | COMMON VARIANTS | POPULATION | INVESTIGATORS | MODIFIERS | SUBTYPES | SUSCEPTIBILITY ALLELES | GENETICS & HEREDITY | GENETIC-VARIANTS | SELECTION | ZNF365 | Genetic Predisposition to Disease | Genome-Wide Association Study | Prognosis | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Gene mutations | Genomics | Physiological aspects | Breast cancer | Genetic aspects | Research | Risk factors | Ovarian cancer | Cancer | Càncer d'ovari | Càncer de mama | Malalties hereditàries | Genètica humana | Genetic diseases | Human genetics | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medical research
Journal Article
Mechanisms of Ageing and Development, ISSN 0047-6374, 01/2009, Volume 130, Issue 1-2, pp. 122 - 127
Search for cancer-predisposing single-nucleotide gene polymorphisms is complicated due to weakness of expected associations. We introduced a novel design for...
Genetic predisposition | Case-control studies | Gene polymorphisms | SNP | Ageing | Cancer | FREE SMOKERS | GENETIC POLYMORPHISMS | HUMAN LONGEVITY | DRUG-METABOLIZING-ENZYMES | P53 | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | BREAST-CANCER | LUNG-CANCER | SUSCEPTIBILITY ALLELES | POOLED-ANALYSIS | ASSOCIATION | Neoplasms - genetics | Bias | Humans | Risk Factors | Aging | Aged | Genetic Predisposition to Disease - epidemiology | Case-Control Studies | Neoplasms - epidemiology | Analysis | Oncology, Experimental | Research | Tumor proteins | Epidemiology
Genetic predisposition | Case-control studies | Gene polymorphisms | SNP | Ageing | Cancer | FREE SMOKERS | GENETIC POLYMORPHISMS | HUMAN LONGEVITY | DRUG-METABOLIZING-ENZYMES | P53 | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | BREAST-CANCER | LUNG-CANCER | SUSCEPTIBILITY ALLELES | POOLED-ANALYSIS | ASSOCIATION | Neoplasms - genetics | Bias | Humans | Risk Factors | Aging | Aged | Genetic Predisposition to Disease - epidemiology | Case-Control Studies | Neoplasms - epidemiology | Analysis | Oncology, Experimental | Research | Tumor proteins | Epidemiology
Journal Article
Nature Genetics, ISSN 1061-4036, 2015, Volume 47, Issue 2, pp. 164 - 171
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibility alleles. The pattern of association at these loci is...
BRCA2 MUTATION CARRIERS | BREAST-CANCER | COMMON VARIANTS | METAANALYSIS | HIGH-RISK | MYOPODIN | GENETICS & HEREDITY | HUMAN ELG1 | ABO BLOOD-GROUP | SINGLE NUCLEOTIDE POLYMORPHISMS | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Humans | Genotype | Risk | Ovarian Neoplasms - genetics | Young Adult | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Adolescent | Alleles | Carcinoma, Ovarian Epithelial | Adult | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | Genome-Wide Association Study - methods | Quantitative Trait Loci | BRCA2 Protein - genetics | Genes, Reporter | Quantitative trait loci | Genetic aspects | Identification and classification | Health aspects | Ovarian cancer | Haplotypes | Accuracy | Population | Hormone replacement therapy | Genomes | Meta-analysis | Cèl·lules epitelials | Càncer d'ovari | Developmental genetics | Human genome | Epithelial cells | Genètica del desenvolupament | Nucleotides | Genoma humà | Nucleòtids | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
BRCA2 MUTATION CARRIERS | BREAST-CANCER | COMMON VARIANTS | METAANALYSIS | HIGH-RISK | MYOPODIN | GENETICS & HEREDITY | HUMAN ELG1 | ABO BLOOD-GROUP | SINGLE NUCLEOTIDE POLYMORPHISMS | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Humans | Genotype | Risk | Ovarian Neoplasms - genetics | Young Adult | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Adolescent | Alleles | Carcinoma, Ovarian Epithelial | Adult | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | Genome-Wide Association Study - methods | Quantitative Trait Loci | BRCA2 Protein - genetics | Genes, Reporter | Quantitative trait loci | Genetic aspects | Identification and classification | Health aspects | Ovarian cancer | Haplotypes | Accuracy | Population | Hormone replacement therapy | Genomes | Meta-analysis | Cèl·lules epitelials | Càncer d'ovari | Developmental genetics | Human genome | Epithelial cells | Genètica del desenvolupament | Nucleotides | Genoma humà | Nucleòtids | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we...
BUCCAL CELLS | GENETIC-VARIATION | COMMON VARIANTS | TERT-CLPTM1L LOCUS | REVERSE-TRANSCRIPTASE | SEQUENCE | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | POLYMORPHISM | FIBROBLASTS | GENOME-WIDE ASSOCIATION | Breast cancer | Genetic aspects | Research | Single nucleotide polymorphisms | Risk factors | Ovarian cancer | Genetics | Mutation | Càncer de mama | Càncer d'ovari | Telòmer | Telomere | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
BUCCAL CELLS | GENETIC-VARIATION | COMMON VARIANTS | TERT-CLPTM1L LOCUS | REVERSE-TRANSCRIPTASE | SEQUENCE | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | POLYMORPHISM | FIBROBLASTS | GENOME-WIDE ASSOCIATION | Breast cancer | Genetic aspects | Research | Single nucleotide polymorphisms | Risk factors | Ovarian cancer | Genetics | Mutation | Càncer de mama | Càncer d'ovari | Telòmer | Telomere | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article